108 related articles for article (PubMed ID: 7724481)
21. In vivo metabolism of brain natriuretic peptide in the rat involves endopeptidase 24.11 and angiotensin converting enzyme.
Vanneste Y; Pauwels S; Lambotte L; Deschodt-Lanckman M
Biochem Biophys Res Commun; 1990 Nov; 173(1):265-71. PubMed ID: 2175178
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes.
Helin K; Tikkanen I; Hohenthal U; Fyhrquist F
Eur J Pharmacol; 1994 Oct; 264(2):135-41. PubMed ID: 7851475
[TBL] [Abstract][Full Text] [Related]
23. Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivation.
Barelli H; Ahmad S; Kostka P; Fox JA; Daniel EE; Vincent JP; Checler F
Peptides; 1989; 10(5):1055-61. PubMed ID: 2575247
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine.
Ward PE; Sheridan MA; Hammon KJ; Erdös EG
Biochem Pharmacol; 1980 Jun; 29(11):1525-9. PubMed ID: 6249319
[No Abstract] [Full Text] [Related]
25. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII.
Farias SL; Sabatini RA; Sampaio TC; Hirata IY; Cezari MH; Juliano MA; Sturrock ED; Carmona AK; Juliano L
Biol Chem; 2006 May; 387(5):611-6. PubMed ID: 16740133
[TBL] [Abstract][Full Text] [Related]
26. Distribution of brush-border membrane peptidases along the rabbit intestine: implication for oral delivery of peptide drugs.
Bai JP
Life Sci; 1993; 52(11):941-7. PubMed ID: 8095314
[TBL] [Abstract][Full Text] [Related]
27. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes.
Mentlein R; Dahms P
J Neurochem; 1994 Jan; 62(1):27-36. PubMed ID: 7903352
[TBL] [Abstract][Full Text] [Related]
28. Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.
Langguth P; Merkle HP; Amidon GL
Pharm Res; 1994 Apr; 11(4):528-35. PubMed ID: 8058610
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
[TBL] [Abstract][Full Text] [Related]
30. Distribution of brush-border membrane peptidases along the rat intestine.
Bai JP
Pharm Res; 1994 Jun; 11(6):897-900. PubMed ID: 7937532
[TBL] [Abstract][Full Text] [Related]
31. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
[TBL] [Abstract][Full Text] [Related]
32. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
[TBL] [Abstract][Full Text] [Related]
33. Neurotensin and neuromedin N undergo distinct catabolic processes in murine astrocytes and primary cultured neurons.
Vincent B; Vincent JP; Checler F
Eur J Biochem; 1994 Apr; 221(1):297-306. PubMed ID: 7909519
[TBL] [Abstract][Full Text] [Related]
34. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
Fink CA; Qiao Y; Berry CJ; Sakane Y; Ghai RD; Trapani AJ
J Med Chem; 1995 Dec; 38(26):5023-30. PubMed ID: 8544178
[TBL] [Abstract][Full Text] [Related]
35. Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
Cao Z; Burrell LM; Tikkanen I; Bonnet F; Cooper ME; Gilbert RE
Kidney Int; 2001 Aug; 60(2):715-21. PubMed ID: 11473654
[TBL] [Abstract][Full Text] [Related]
36. Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
J Cardiovasc Pharmacol; 2003 Feb; 41(2):254-64. PubMed ID: 12548087
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin.
Mullally MM; Meisel H; FitzGerald RJ
FEBS Lett; 1997 Feb; 402(2-3):99-101. PubMed ID: 9037174
[TBL] [Abstract][Full Text] [Related]
38. Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.
Jullien N; Makritis A; Georgiadis D; Beau F; Yiotakis A; Dive V
J Med Chem; 2010 Jan; 53(1):208-20. PubMed ID: 19899765
[TBL] [Abstract][Full Text] [Related]
39. A computational approach to the study of the binding mode of dual ACE/NEP inhibitors.
Dimitropoulos N; Papakyriakou A; Dalkas GA; Sturrock ED; Spyroulias GA
J Chem Inf Model; 2010 Mar; 50(3):388-96. PubMed ID: 20170101
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.
Welches WR; Brosnihan KB; Ferrario CM
Life Sci; 1993; 52(18):1461-80. PubMed ID: 8387132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
